Genesis Energy, L.P. Announces Public Offering of Senior Notes
HOUSTON–(BUSINESS WIRE)–Genesis Energy, L.P. (NYSE: GEL) today announced the commencement, subject to market and other conditions, of a registered, underwritten... Read more.
QPharma Launches Innovative Digital Sampling Platform for Healthcare Provider Engagement at Medical Congresses
MORRISTOWN, N.J.–(BUSINESS WIRE)–QPharma®, a leader in compliant HCP engagement and sampling solutions, launches a next‑generation digital sampling... Read more.
Liberty Global Reports Q4 2025 Results
Improving commercial momentum and continued focus on value creation DENVER, Colorado–(BUSINESS WIRE)–Liberty Global Ltd. announces its Q4 2025 financial... Read more.
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement
Acquisition of Faeth and concurrent $200 million private investment positions the combined company to advance its pipeline across key clinical milestones in endometrial... Read more.
Palogic Value Fund Withdraws Nominees and Shareholder Proposal at Pebblebrook Hotel Trust
Highlights Persistent Concerns About NAV Accretion, Executive Accountability, and Economic Alignment Encourages Board to Explore Asset Sales to Accelerate Share... Read more.
Diodes Incorporated to Participate at Upcoming Financial Conferences
PLANO, Texas–(BUSINESS WIRE)–Diodes Incorporated (Nasdaq: DIOD), today announced the Company’s participation in the following financial conferences:... Read more.
GSK’s AREXVY Associated With Reductions in Certain RSV-Related Risks Including Heart Attack, Stroke and Severe Flare-Ups of COPD and Asthma, Real World Study Shows
Reduction observed in RSV-related hospitalizations in adults aged ≥60 years1 An observed reduction in major adverse cardiovascular events* in adults aged ≥60... Read more.
Affinia Therapeutics Receives European Medicines Agency Orphan Drug Designation for AFTX-201 in BAG3-Associated Dilated Cardiomyopathy (DCM)
BAG3 DCM is a devastating genetic heart disease caused by a mutation in the BAG3 gene and resulting in loss of heart function at a young age; despite current standard... Read more.
Sharon AI Announces Nasdaq Listing and Pricing of $125 Million U.S. Initial Public Offering
NEW YORK–(BUSINESS WIRE)–SharonAI Holdings Inc. and its subsidiaries (“Sharon AI” or the “Company”), a leading Australian Neocloud, today announced... Read more.
Delta Galil Reports Fourth Quarter and Full Year 2025 Results
Record Fourth Quarter and Full Year Sales Record Fourth Quarter Direct-To-Consumer Sales Record Fourth Quarter Gross Profit Expanded 5% to $263.2 Million Strong... Read more.